Development of nanoparticle-based magnetic resonance colonography
Jihong Sun
Department of Radiology, Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou City, Zhejiang Province, China
Image-Guided Bio-Molecular Interventions Section, Department of Radiology, University of Washington School of Medicine, Seattle, Washington, USA
Search for more papers by this authorWeiliang Zheng
Department of Radiology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou City, Zhejiang Province, China
Search for more papers by this authorHui Zhang
Department of Pharmacology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou City, Zhejiang Province, China
Search for more papers by this authorTao Wu
Department of Radiology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou City, Zhejiang Province, China
Search for more papers by this authorHong Yuan
College of Pharmaceutical Sciences, Zhejiang University, Hangzhou City, Zhejiang Province, China
Search for more papers by this authorXiaoming Yang
Image-Guided Bio-Molecular Interventions Section, Department of Radiology, University of Washington School of Medicine, Seattle, Washington, USA
Department of Radiology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou City, Zhejiang Province, China
Search for more papers by this authorCorresponding Author
Shizheng Zhang
Department of Radiology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou City, Zhejiang Province, China
Department of Radiology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, 3 East Qingchun Road, Hangzhou, Zhejiang, People's Republic of China===Search for more papers by this authorJihong Sun
Department of Radiology, Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou City, Zhejiang Province, China
Image-Guided Bio-Molecular Interventions Section, Department of Radiology, University of Washington School of Medicine, Seattle, Washington, USA
Search for more papers by this authorWeiliang Zheng
Department of Radiology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou City, Zhejiang Province, China
Search for more papers by this authorHui Zhang
Department of Pharmacology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou City, Zhejiang Province, China
Search for more papers by this authorTao Wu
Department of Radiology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou City, Zhejiang Province, China
Search for more papers by this authorHong Yuan
College of Pharmaceutical Sciences, Zhejiang University, Hangzhou City, Zhejiang Province, China
Search for more papers by this authorXiaoming Yang
Image-Guided Bio-Molecular Interventions Section, Department of Radiology, University of Washington School of Medicine, Seattle, Washington, USA
Department of Radiology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou City, Zhejiang Province, China
Search for more papers by this authorCorresponding Author
Shizheng Zhang
Department of Radiology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou City, Zhejiang Province, China
Department of Radiology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, 3 East Qingchun Road, Hangzhou, Zhejiang, People's Republic of China===Search for more papers by this authorAbstract
This study was to develop a novel method of nanoparticle-based MR colonography. Two types of solid lipid nanoparticles (SLNs) were synthesized with loading of (a) gadolinium (Gd) diethylenetriaminepenta acetic acid to construct Gd-SLNs as an MR T1 contrast agent and (b) otcadecylamine-fluorescein-isothiocyanate to construct Gd-fluorescein isothiocyanate (FITC)-SLNs for histologic confirmation of MR findings. Through an in vitro experiment, we first evaluated the size distribution and gadolinium diethylenetriaminepenta acetic acid entrapment efficiency of these SLNs. The SLNs displayed a size distribution of 50–300 nm and a gadolinium diethylenetriaminepenta acetic acid entrapment efficiency of 56%. For in vivo validation, 30 mice were divided into five groups, each of which was administered a transrectal enema using: (i) Gd-SLNs (n = 6); (ii) Gd-FITC-SLNs (n = 6); (iii) blank SLNs (n = 6); (iv) gadolinium diethylenetriaminepenta acetic acid (n = 6); and (v) water (n = 6). T1-weighted fluid-attenuated inversion-recovery MRI was then performed on mice after transrectal infusion of Gd-SLNs or Gd-FITC-SLNs, which demonstrated bright enhancement of the colonic walls, with decrease in T1 relaxation time. When Gd-FITC-SLNs were delivered, green fluorescent spots were visualized in both the extracelluar space and the cytoplasm through colonic walls under confocal microscopy and fluorescence microscopy. This study establishes the “proof-of-principle” of a new imaging technique, called “nanoparticle-based MR colonography,” which may provide a useful imaging tool for the diagnosis of colorectal diseases. Magn Reson Med, 2011. © 2010 Wiley-Liss, Inc.
REFERENCES
- 1 Kung JW, Levine MS, Glick SN, Lakhani P, Rubesin SE, Laufer I. Colorectal cancer: screening double-contrast barium enema examination in average-risk adults older than 50 years. Radiology 2006; 240: 725–735.
- 2 Gluecker TM, Johnson CD, Harmsen WS, Offord KP, Harris AM, Wilson LA, Ahlquist DA. Colorectal cancer screening with CT colonography, colonoscopy, and double-contrast barium enema examination: prospective assessment of patient perceptions and preferences. Radiology 2003; 227: 378–384.
- 3 Hartmann D, Bassler B, Schilling D, Adamek HE, Jakobs R, Pfeifer B, Eickhoff A, Zindel C, Riemann JF, Layer G. Colorectal polyps: detection with dark-lumen MR colonography versus conventional colonoscopy. Radiology 2006; 238: 143–149.
- 4 Runge VM, Stewart RG, Clanton JA, James AE, Partain CL. Work in progress: potential oral and intravenous paramagnetic NMR contrast agents. Radiology 1983; 147: 789–791.
- 5 Nagata K, Singh AK, Sangwaiya MJ, Näppi J, Zalis ME, Cai W, Yoshida H. Comparative evaluation of the fecal-tagging quality in CT colonography: barium vs. iodinated oral contrast agent. Acad Radiol 2009; 16: 1393–1399.
- 6 Ott DJ, Gelfand DW, Wu WC, Ablin DS. Colon polyp morphology on double-contrast barium enema: its pathologic predictive value. Am J Roentgenol 1983; 141: 965–970.
- 7 Johansen JG. Assessment of a non-ionic contrast medium (Amipaque) in the gastrointestinal tract. Invest Radiol 1978; 13: 523–527.
- 8 Laniado M, Kornmesser W, Hamm B, Clauss W, Weimann HJ, Felix R. MR imaging of the gastrointestinal tract: value of Gd-DTPA. Am J Roentgenol 1988; 150: 817–821.
- 9 Ferrari M. Cancer nanotechnology: opportunities and challenges. Nat Rev Cancer 2005; 5: 161–171.
- 10 Couvreur P, Vauthier C. Nanotechnology: intelligent design to treat complex disease. Pharm Res 2006; 23: 1417–1450.
- 11 Artemov D, Bhujwalla ZM, Bulte JW. Magnetic resonance imaging of cell surface receptors using targeted contrast agents. Curr Pharm Biotechnol 2004; 5: 485–494.
- 12 Aime S, Cabella C, Colombatto S, Geninatti Crich S, Gianolio E, Maggioni F. Insights into the use of paramagnetic Gd(III) complexes in MR-molecular imaging investigations. J Magn Reson Imaging 2002; 16: 394–406.
- 13 Weissleder R, Mahmood U. Molecular imaging. Radiology 2001; 219: 316–333.
- 14 Yuan H, Chen J, Du YZ, Hu FQ, Zeng S, Zhao HL. Studies on oral absorption of stearic acid SLN by a novel fluorometric method. Colloids Surf B Biointerfaces 2007; 58: 157–164.
- 15 Humberstone AJ, Charman WN. Lipid-based vehicles for the oral delivery of poorly water soluble drugs. Adv Drug Deliv Rev 1997; 25: 103–128.
- 16 Morel S, Terreno E, Ugazio E, Aime S, Gasco MR. NMR relaxometric investigations of solid lipid nanoparticles (SLN) containing gadolinium(III) complexes. Eur J Pharm Biopharm 1998; 45: 157–163.
- 17 Müller RH, Mäder K, Gohla S. Solid lipid nanoparticles (SLN) for controlled drug delivery – a review of the state of the art. Eur J Pharm Biopharm 2000; 50: 161–177.
- 18 Pedersen N, Hansen S, Heydenreich AV, Kristensen HG, Poulsen HS. Solid lipid nanoparticles can effectively bind DNA, streptavidin and biotinylated ligands. Eur J Pharm Biopharm 2006; 62: 155–162.
- 19 Yuan H, Huang LF, Du YZ, Ying XY, You J, Hu FQ, Zeng S. Solid lipid nanoparticles prepared by solvent diffusion method in a nanoreactor system. Colloids Surf B Biointerfaces 2008; 61: 132–137.
- 20 de Bazelaire CM, Duhamel GD, Rofsky NM, Alsop DC. MR imaging relaxation times of abdominal and pelvic tissues measured in vivo at 3.0 T: preliminary results. Radiology 2004; 230: 652–659.
- 21 Mamisch TC, Dudda M, Hughes T, Burstein D, Kim YJ. Comparison of delayed gadolinium enhanced MRI of cartilage (dGEMRIC) using inversion recovery and fast T1 mapping sequences. Magn Reson Med 2008; 60: 768–773.
- 22 Yang X. Nano- and microparticle-based imaging of cardiovascular interventions: overview. Radiology 2007; 243: 340–347.
- 23 Desai MP, Labhasetwar V, Amidon GL, Levy RJ. Gastrointestinal uptake of biodegradable microparticles: effect of particle size. Pharm Res 1996; 13: 1838–1845.
- 24 Damge C, Michel C, Aprahamian M, Couvreur P, Devissaguet JP. Nanocapsules as carriers for oral peptide delivery. J Control Release 1990; 13: 233–239.
- 25 Sanders E, Ashworth CT. A study of particulate intestinal absorption and hepatocellular uptake. Use of polystyrene latex particles. Exp Cell Res 1961; 22: 137–145.
- 26 Rinck PA. Magnetic resonance in medicine. Oxford: Blackwell Scientific Publication; 2003.
- 27 Runge VM. Safety of approved MR contrast media for intravenous injection. J Magn Reson Imaging 2000; 12: 205–213.
- 28 Caravan P, Ellison JJ, McMurry TJ, Lauffer RB. Gadolinium (III) chelates as MRI contrast agents: Structure, Dynamics and Applications. Chem Rev 1999; 99: 2293–2352.
- 29 Weinmann HJ, Brasch RC, Press WR, Wesbey GE. Characteristics of gadolinium-DTPA complex: a potential NMR contrast agent. Am J Roentgenol 1984; 142: 619–624.
- 30 Bargoni A, Cavalli R, Caputo O, Fundaro A, Gasco MR, Zara GP. Solid lipid nanoparticles in lymph and plasma after duodenal administration to rats. Pharm Res 1998; 15: 745–750.
- 31 Chen HH, Le Visage C, Qiu B, Du X, Ouwerkerk R, Leong KW, Yang X. MR imaging of biodegradable polymeric microparticles: a potential method of monitoring local drug delivery. Magn Reson Med 2005; 53: 614–620.